Search

Your search keyword '"Mumps epidemiology"' showing total 1,239 results

Search Constraints

Start Over You searched for: Descriptor "Mumps epidemiology" Remove constraint Descriptor: "Mumps epidemiology"
1,239 results on '"Mumps epidemiology"'

Search Results

1. Characteristics of reported mumps cases in the United States: 2018-2023.

2. Modeling the population-level impact of a third dose of MMR vaccine on a mumps outbreak at the University of Iowa.

3. Epidemiological characteristics of breakthrough mumps infection cases from 2019 to 2023 in Chongqing, China.

4. Epidemiological characteristics and interrupted time series analysis of mumps in Quzhou City, 2005-2023.

5. Genomic Characterization of Three Canadian Mumps Outbreaks Demonstrates Endemic Transmission in Canada.

6. Epidemiological characteristics and serological survey of mumps 15 years after MMR vaccine was included in the immunization program.

7. Vaccination Against Mumps, Aren't We Late Already?

8. Genetic characteristic of mumps virus from 2012 to 2016 and its serum antibody level among general healthy population during 2018-2020 in Jiangsu Province, China.

10. Assessing seropositivity of MMR antibodies in individuals aged 2-22: evaluating routine vaccination effectiveness after the 2003 mass campaign-a study from Iran's National Measles Laboratory.

11. Possible counter-intuitive impact of local vaccine mandates for vaccine-preventable infectious diseases.

13. The impact of temperature, humidity and closing school on the mumps epidemic: a case study in the mainland of China.

14. Molecular characterization of Mumps virus genotype C detected from Dibrugarh district of Assam, India.

15. Measles, mumps, and rubella vaccination coverage: an ecological study of primary health care and socio-economic factors in Catalonia, Spain.

16. Mumps in Poland in 2021.

17. Immunity against measles, mumps, rubella, and varicella among homeless individuals in Germany - A nationwide multi-center cross-sectional study.

18. Is vaccination against measles, mumps, and rubella associated with reduced rates of antibiotic treatments among children below the age of 2 years? Nationwide register-based study from Denmark, Finland, Norway, and Sweden.

19. Recent Surge in Mumps Cases in India: Need for Urgent Remedial Measures.

20. We Need a New Mumps Vaccine.

21. A national registry-based study on uptake of the first dose of MMR vaccine in 380 administrative regions in Poland, 2013-2016-2020.

23. Estimation of the infection attack rate of mumps in an outbreak among college students using paired serology.

24. Measles vaccination - An underestimated prevention measure: Analyzing a fatal case in Hildesheim, Germany.

25. What is the relevancy of a surveillance of mumps without a systematic laboratory confirmation in highly immunized populations? Epidemiology of suspected and biologically confirmed mumps cases seen in general practice in France between 2014 and 2020.

26. [Epidemiological characteristics of mumps among people aged 0-14 in Jiangxi Province, 2015-2022].

27. Vaccine-preventable diseases: Immune response in a large population of healthcare students.

30. Measles, mumps, rubella and varicella antibodies among international and domestic university students.

32. Impact of pregnancy vaccine uptake and socio-demographic determinants on subsequent childhood Measles, Mumps and Rubella vaccine uptake: A UK birth cohort study.

33. Mumps-specific antibody persistence in children aged 3-7 years immunized with two doses of mumps-containing vaccines: A prospective cohort study in Jiangsu Province, China.

34. Investigating Local Patterns of Mumps Virus Circulation, Using a Combination of Molecular Tools.

35. [Application of autoregressive integrated moving average model to predict and analyze the incidence trend of mumps in Jiangxi Province].

36. Estimated number of reported vaccine-preventable disease cases averted following the introduction of routine vaccination programs in Sweden, 1910-2019.

37. Measles in vulnerable populations: An outbreak in Roma settlements of Loire-Atlantique, France, 2019.

38. Direct and crowding-out effects of a Hepatitis B vaccination campaign.

39. Prenatal Exposure to Poly- and Perfluoroalkyl Substances (2009-2014) and Vaccine Antibody Titers of Measles, Mumps, Rubella, and Varicella in Children Four to Eight Years Old from the Healthy Start Cohort.

40. Epidemiological characteristics of seven notifiable respiratory infectious diseases in the mainland of China: an analysis of national surveillance data from 2017 to 2021.

41. Mumps.

42. Susceptibility of nursery teachers to measles, rubella, varicella and mumps in Japan.

43. Seroprevalence of Measles, Mumps, Rubella, and Varicella-Zoster Virus and Seroresponse to the Vaccinations in Adult Solid Organ Transplant Candidates.

44. Mumps epidemic dynamics in the United States before vaccination (1923-1932).

45. Quantification of Waning Immunity After Measles Vaccination-Evidence From a Seroprevalence Study.

46. Co-circulation of two Mumps virus genotypes in Assam, India.

47. Measles and Rubella Seroprevalence Among Children and Adolescents of Córdoba, Argentina: A Cross-Section Study in the Context of the Elimination Program.

48. Investigation of the Seroprevalence of Antimeasles Immunoglobulin G Antibody in Students at Shiraz University of Medical Sciences.

49. Epidemiology of mumps, mumps complications, and mumps orchitis in Korea using the National Health Insurance Service database.

50. Mumps resurgence in a highly vaccinated population: Insights gained from surveillance in Canada, 2002-2020.

Catalog

Books, media, physical & digital resources